* Weight loss jab could reduce heart attack risk, study finds BBC.com
* Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial Nature.com
* Ozempic found to cut heart disease and keep weight off for four years Euronews
* Weight loss drug could reduce heart attack risk by 20%, study finds The Guardian
* People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says CNBC
http://dlvr.it/T6vnGG
* Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial Nature.com
* Ozempic found to cut heart disease and keep weight off for four years Euronews
* Weight loss drug could reduce heart attack risk by 20%, study finds The Guardian
* People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says CNBC
http://dlvr.it/T6vnGG